MARKETS
Markets

Matinas Biopharma Terminates Agreement With Former Financial Advisor On Nov 3, 2026

Nov 3, 2026 · 05:34 PM ET· updated 1h ago

On November 3, 2026, Matinas BioPharma Holdings, Inc. (the "Company") and a former financial advisor to the Company (the "Advisor") terminated the agreement between the Company and the Advisor. That

Share
Why It Matters

Matinas BioPharma ended its contract with a financial advisor. When companies change advisors, watch to see if new leadership brings fresh ideas or signals.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.